Business / Finance

RSS

ADC Therapeutics, BZL Biologics sign licensing deal for antibody against PSMA-positive prostate cancers

ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and BZL Biologics LLC, of New York, today announced an exclusive licensing and collaboration agreement for an antibody against PSMA-positive prostate cancers.

15 Jul 2013

Ipsen closes acquisition of UK-based Syntaxin

Ipsen announced today the closing of the acquisition of Syntaxin, a UK-based private life sciences company specialized in botulinum toxin engineering.

15 Jul 2013

PathoQuest closes new fundraising of EUR 3.8 million

PathoQuest, a new generation molecular diagnostics company that offers a new approach based on NGS (Next Generation Sequencing) in the field of infectious diseases, announces today the closing of a new fundraising of EUR 3.8 million.

12 Jul 2013

Boehringer Ingelheim signs multi-year renewal agreement to NextBio Research Platform

NextBio, whose Big Data technology enables users to apply genomic data from disparate sources in novel and useful ways across life sciences research, today announced that Boehringer Ingelheim has signed a multi-year renewal agreement to the NextBio Research Platform.

9 Jul 2013

Acorda Therapeutics acquires two neuropathic pain management assets from NeurogesX

Acorda Therapeutics, Inc. today announced that it has acquired two neuropathic pain management assets from NeurogesX, Inc. Qutenza is approved by the U.S. Food and Drug Administration for the management of neuropathic pain associated with postherpetic neuralgia.

9 Jul 2013

Glythera secures £700k to advance development of new generation of biological therapeutics

Glythera Ltd is delighted to announce that it has successfully achieved a number of technical and commercial milestones which has resulted in the release of a second tranche of funding totalling £700k from IP Group and its managed fund, the Finance for Business North East Technology Fund.

9 Jul 2013

Leica Biosystems announces acquisition of Kreatech Diagnostics

Leica Biosystems announced that it has acquired Kreatech Diagnostics, a privately-held provider of DNA fluorescent in-situ hybridization probes and target labeling reagents for microarrays.

9 Jul 2013

BioNano Genomics signs strategic partnership with New York Genome Center

BioNano Genomics and the New York Genome Center announced today a strategic partnership between the two institutions that includes the purchase of an Irys System by NYGC.

8 Jul 2013

Life Care Medical Devices inks exclusive distribution agreement with M.E.D. Surgical

Life Care Medical Devices Ltd., a development stage medical device company today announced that Life Care Medical Devices, Ltd, Ireland signed an exclusive agreement with M.E.D. Surgical, a subsidiary of Sisk Healthcare for the distribution of the Company's Keyhole Cup Laparoscopic Access Device in the Republic of Ireland territories and Northern Ireland.

8 Jul 2013

Soligenix announces personalized medicine collaboration with SciClone

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced a personalized medicine collaboration with SciClone Pharmaceuticals in the Company's oral mucositis clinical program with SGX942.

8 Jul 2013

Capricor to become wholly-owned subsidiary of Nile Therapeutics

Capricor, Inc., a privately held biotechnology company developing cardiac stem cell therapeutics to repair damaged heart muscle, and Nile Therapeutics, Inc. announced today that they have entered into a Merger Agreement under which Capricor will become a wholly-owned subsidiary of Nile Therapeutics, Inc. in an all-stock transaction.

8 Jul 2013

HeadSense closes financing for non-invasive intracranial pressure monitor

HeadSense, an early stage company developing a non-invasive neurological monitor focused initially on an intracranial pressure application, today announced it closed financing led by Pontifax, a leading Israeli VC; GE Ventures of Menlo Park, California, USA; Everett Partners, an investment group based out of Akron, Ohio, USA; and JuMaJo, an investment group from Hamburg, Germany.

8 Jul 2013

Hemp signs distribution agreement with CleanPath for new memory enhancing nutraceutical

Hemp, Inc. announces its first $200,000 sale after inking an exclusive agreement with CleanPath Resources Corp. This agreement is for CleanPath to distribute Hemp, Inc.'s life-changing nutraceutical, "Focus", which is designed to support "Clearer Thinking" and "Improve Memory".

8 Jul 2013

Bioniche, Paladin close debt refinancing agreement and sign first licensing deal for Urocidin

Bioniche Life Sciences Inc. and Paladin Labs Inc. today announced the official closing of the various agreements associated with a comprehensive strategic collaboration to refinance and increase Bioniche's debt, provide new equity, and enter into the first licensing deal for Bioniche's Phase III bladder cancer product - Urocidin.

6 Jul 2013

Neusoft Medical signs agreements to take 25% equities in PNMS from Philips

Neusoft Corporation, a leading IT solution and service provider in China, announced that Neusoft's wholly owned subsidiary, Neusoft Medical Systems Co., Ltd. has signed agreements with Royal Philips Electronics and its affiliate company on the equities and assets transfer, intellectual property rights, contracted manufacturing and supply, components supply, customer service and support of Philips & Neusoft Medical Systems Co., Ltd.

6 Jul 2013

Skanska inks contract to renovate Williamson County Hospital District, USA

Skanska has signed a contract with Williamson County Hospital District, Tennessee, USA to perform hospital additions and renovations on its campus.

5 Jul 2013

Pathway Genomics collaborates with Singapore-based company, Parkway Laboratory Services

Pathway Genomics Corporation, a San Diego-based clinical laboratory that offers genetic testing services internationally, has partnered with Parkway Laboratory Services Ltd, an ancillary service of Parkway Pantai Limited, the largest private healthcare provider in Singapore, and one of the largest private healthcare providers in Asia.

1 Jul 2013

MAXIMUS completes acquisition of Health Management Limited

MAXIMUS (NYSE:MMS) announced today that it has completed the acquisition of Health Management Limited, an independent provider of occupational health care services in the United Kingdom.

1 Jul 2013

Manage My Practice, UBM Medica US form marketing and distribution partnership

ManageMyPractice.com, a medical practice management information and resource website, announced today a unique marketing and distribution partnership with UBM Medica US.

27 Jun 2013

Seattle Genetics collaborates with Bayer HealthCare for new antibody-drug conjugate

Seattle Genetics, Inc. today announced that it has entered into a new antibody-drug conjugate (ADC) collaboration with Bayer HealthCare (Bayer). Under the latest relationship, Bayer will pay upfront and option exercise fees of up to $20 million for worldwide rights to utilize Seattle Genetics' auristatin-based ADC technology with antibodies to several oncology targets.

25 Jun 2013

Business / Finance

ADC Therapeutics, BZL Biologics sign licensing deal for antibody against PSMA-positive prostate cancers

Ipsen closes acquisition of UK-based Syntaxin

PathoQuest closes new fundraising of EUR 3.8 million

Boehringer Ingelheim signs multi-year renewal agreement to NextBio Research Platform

Acorda Therapeutics acquires two neuropathic pain management assets from NeurogesX

Glythera secures £700k to advance development of new generation of biological therapeutics

Leica Biosystems announces acquisition of Kreatech Diagnostics

BioNano Genomics signs strategic partnership with New York Genome Center

Life Care Medical Devices inks exclusive distribution agreement with M.E.D. Surgical

Soligenix announces personalized medicine collaboration with SciClone

Capricor to become wholly-owned subsidiary of Nile Therapeutics

HeadSense closes financing for non-invasive intracranial pressure monitor

Hemp signs distribution agreement with CleanPath for new memory enhancing nutraceutical

Bioniche, Paladin close debt refinancing agreement and sign first licensing deal for Urocidin

Neusoft Medical signs agreements to take 25% equities in PNMS from Philips

Skanska inks contract to renovate Williamson County Hospital District, USA

Pathway Genomics collaborates with Singapore-based company, Parkway Laboratory Services

MAXIMUS completes acquisition of Health Management Limited

Manage My Practice, UBM Medica US form marketing and distribution partnership

Seattle Genetics collaborates with Bayer HealthCare for new antibody-drug conjugate

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News